An increasing number of cystic neoplasms of the pancreas have been detected with the progress of radiologic modalities. These cystic tumors include solid pseudopapillary tumor, serous cystadenoma, mucinous cystic tumor, and intraductal papillary mucinous tumor. The latter two lesions have been reported under a clinical nickname of ‘mucin-hypersecreting’ cystic tumor. In the diagnosis of cystic neoplasms of the pancreas, clinical findings such as age, sex and location of lesion were informative. US and CT were useful to check up the presence of cystic lesion of the pancreas. ERCP was useful to examine the cystic lesion but it has some limitations. ERCP did not visualize the cystic lesion when the lesion was filled with excessive mucin. MRI (T2-weighted image) and magnetic resonance cholangiopancreatography were powerful to display the entire cystic lesion. In the assessment of grade of malignancy, EUS was valuable to demonstrate the precise internal structures such as mural nodule. In this communication, radiologic diagnosis of cystic tumor of the pancreas was briefly reviewed focussing on ‘mucin-hypersecreting’ tumor of the pancreas.

Keywords:
Intraductal papillary-mucinous tumor, Mucinous cystic tumor, Serous cystadenoma, Solid pseudopapillary tumor
This content is only available via PDF.
© 2001 S. Karger AG, Basel and IAP
2001
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.